These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 37242462)

  • 41. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rosiglitazone may reduce non-melanoma skin cancer risk in Taiwanese.
    Tseng CH
    BMC Cancer; 2015 Feb; 15():41. PubMed ID: 25655946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rosiglitazone is not associated with an increased risk of bladder cancer.
    Tseng CH
    Cancer Epidemiol; 2013 Aug; 37(4):385-9. PubMed ID: 23619142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    J Am Acad Dermatol; 2018 Apr; 78(4):694-700. PubMed ID: 29246826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metformin use is associated with a lower risk of osteoporosis/vertebral fracture in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Eur J Endocrinol; 2021 Feb; 184(2):299-310. PubMed ID: 33270043
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of Psoriasis in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Matched Cohort Study.
    Moon JM; Lee JY; Koh SJ; Park H; Kang S; Soh H; Lee HJ; Im JP; Kim JS
    Dermatology; 2021; 237(3):330-337. PubMed ID: 33556947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database.
    Yu HC; Chen TP; Chang YC
    J Dent Sci; 2018 Sep; 13(3):242-247. PubMed ID: 30895127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.